|
|
Line 205: |
Line 205: |
| 3. Make HT115(CRISPR-GFP #7) competent and make freeze stock | | 3. Make HT115(CRISPR-GFP #7) competent and make freeze stock |
| <br /> | | <br /> |
- |
| |
- |
| |
- | <tr>
| |
- | <td colspan="7">
| |
- | <h3 style="font-family:Verdana; font-weight:700;background-color: #F0F0F0;">'''Week 14:'''</h3>
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/13/2011 </span>
| |
- | <br />
| |
- | 1. Check quality of gDNA
| |
- | <br />
| |
- | 2. Make HT115 + BL21 (tetO, CRISPR-GFP #7) competent cells, freeze stock
| |
- | <br />
| |
- | 3. Miniprep PCDF+casO
| |
- | <br />
| |
- | C. Plate 4 Well 16O (LovTAP Composite)
| |
- | <br />
| |
- | 4. Digest tetO/tetR
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/15/2011 </span>
| |
- | <br />
| |
- | 1. Run a gel of all minipreped PCDF+casO<br />
| |
- | <br />
| |
- | 2. PCR HT115, DH5α2, DH5α3 with primers<br />
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/18/2011 </span>
| |
- | <br />
| |
- | 1. Inoculate the following:
| |
- | <br />
| |
- | BL21 tetO::GFP
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7, cas3
| |
- | <br />
| |
- | HT115 tetO::GFP
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7, cas3
| |
- | <br />
| |
- | HT115 CRISPR::GFP #7
| |
- |
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/19/2011 </span>
| |
- | <br />
| |
- | 1. Growth test, grow all the bacteria overnight<br />
| |
- | <br />
| |
- | 2. PCR cas3+casO from gDNA
| |
- | <br />
| |
- |
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/20/2011 </span>
| |
- | <br />
| |
- | 1. Make biobrick of cas3 and casO
| |
- | <br />
| |
- | 2. Run a gel for cas3 and casO
| |
- | <br />
| |
- | 3. Purify cas3 and casO
| |
- | <br />
| |
- | 4. New experiment: dilution the bacteria to 1000 and 5000 cells and plate them
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/21/2011 </span>
| |
- | <br />
| |
- | 1. Do growth test for the following:
| |
- | <br />
| |
- | BL21 tetO::GFP-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7, cas3-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7, cas3+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7, cas3+IPTG an hour later
| |
- | <br />
| |
- | HT115 tetO::GFP-IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP+IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP+IPTG an hour later
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7-IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7+IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7+IPTG an hour later
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7, cas3-IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7, cas3+IPTG
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7, cas3+IPTG an hour later
| |
- | <br />
| |
- | HT115 CRISPR::GFP #7-IPTG
| |
- | <br />
| |
- | HT115 CRISPR::GFP #7+IPTG
| |
- | <br />
| |
- | HT115 CRISPR::GFP #7+IPTG an hour later
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP#7, cas3
| |
- | <br />
| |
- | HT115 tetO::GFP
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7
| |
- | <br />
| |
- | HT115 tetO::GFP, CRISPR::GFP#7, cas3
| |
- | <br />
| |
- | HT115 CRISPR::GFP #7
| |
- | <br />
| |
- | 2. Dilution: plate on Amp #4 and #5 +/- IPTG, #4 and #5 have different OD values. Dilute 1000* and 5000* to both of them
| |
- | <br />
| |
- | 3. Digest pSB1C3 and tetO/R vector
| |
- | <br />
| |
- | 4. Transform casO#1, #2, #1, #2 on CM plates
| |
- | <br />
| |
- |
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/22/2011 </span>
| |
- | <br />
| |
- | 1. Inoculation casO and cas3 into 24 tubes Notes: casO#1 goes to 1-6, casO#2 goes to 7-12; cas3#1 goes to another 1-6, cas3#2 goes to another 7-12
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/23/2011 </span>
| |
- | <br />
| |
- | 1. Mini-prep all the casO and cas3 samples
| |
- | <br />
| |
- | 2. Digest them by different enzymes
| |
- | <br />
| |
- | 3. Ligate them with pSB1C3 vectors
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/24/2011 </span>
| |
- | <br />
| |
- | 1. Transform all the ligated products into competent cells
| |
- | <br />
| |
- | 2. Inoculate them in LB media
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/25/2011 </span>
| |
- | <br />
| |
- | 1. Mini-prep the biobrick products
| |
- | <br />
| |
- | 2. Verify them by PCR
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/25/2011 </span>
| |
- | <br />
| |
- | 1. Transform
| |
- | the casO plasmid into BL21; cas3; tetO::GFP; CRISPR-GFP
| |
- | <br />
| |
- | 2. Inoculate the above plasmids
| |
- | <br />
| |
- |
| |
- | <span style="font-family:Verdana; font-weight:700;"> 09/27/2011 </span>
| |
- | <br />
| |
- | 1. Do growth test for the following BL21 cells:
| |
- | <br />
| |
- | BL21 tetO::GFP-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP+IPTG(2 hours later)
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+IPTG(2 hours later)
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+IPTG(2 hours later)
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E+IPTG(2 hours later)
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2-IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2+IPTG
| |
- | <br />
| |
- | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2+IPTG(2 hours later)
| |
- | <br />
| |
- |
| |
- |
| |
- | </table>
| |